Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Essential thrombocytosis].

G Van Camp

    Acta Clinica Belgica
    |January 1, 1989
    PubMed
    Summary
    This summary is machine-generated.

    Essential thrombocythemia (ET) involves high platelet counts and can cause bleeding or clotting. In ET patients, platelet dysfunction, not just high counts, may drive dangerous thromboembolic events.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Search for a genetic cause in children with unilateral isolated microtia and congenital aural atresia.

    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·2022
    Same author

    Heart failure with preserved ejection fraction or non-cardiac dyspnea in paroxysmal atrial fibrillation: The role of left atrial strain.

    International journal of cardiology·2020
    Same author

    Hotspot DAXX, PTCH2 and CYFIP2 mutations in pancreatic neuroendocrine neoplasms.

    Endocrine-related cancer·2018
    Same author

    The reduction in glutamate release is predictive of cognitive and emotional alterations that are corrected by the positive modulator of AMPA receptors S 47445 in perinatal stressed rats.

    Neuropharmacology·2018
    Same author

    Primary tumor sidedness has an impact on prognosis and treatment outcome in metastatic colorectal cancer: results from two randomized first-line panitumumab studies.

    Annals of oncology : official journal of the European Society for Medical Oncology·2017
    Same author

    Loss of function of <i>Ywhah</i> in mice induces deafness and cochlear outer hair cells' degeneration.

    Cell death discovery·2016
    Same journal

    MEFV variants as phenotypic modifiers in ankylosing spondylitis: a genetic interaction analysis with HLA-B27.

    Acta clinica Belgica·2026
    Same journal

    What Europe should (not) learn from the new Dietary Guidelines for Americans.

    Acta clinica Belgica·2026
    Same journal

    Real-world evidence on In-hospital statin use and mortality in geriatric patients.

    Acta clinica Belgica·2026
    Same journal

    TKI-associated proteinuria and nephrotic syndrome: a narrative review with clinical illustration in radio-iodine-refractory thyroid cancer.

    Acta clinica Belgica·2026
    Same journal

    A decade of insulin pump therapy in a Belgian paediatric diabetes centre: longitudinal outcomes and evolving practices.

    Acta clinica Belgica·2026
    Same journal

    Pneumococcal vaccination in Belgian adults: a practical translation of the 2025 Superior Health Council guidelines.

    Acta clinica Belgica·2026
    See all related articles

    Area of Science:

    • Hematology
    • Oncology
    • Internal Medicine

    Background:

    • Essential thrombocythemia (ET) is a clonal myeloproliferative disorder.
    • ET is characterized by thrombocytosis, leading to hemorrhagic and thromboembolic complications.
    • Neurologic manifestations are common in ET due to cerebral microvasculature obstruction.

    Observation:

    • A patient with Essential thrombocythemia presented with vertebral artery thrombosis and a secondary embolic event.
    • The patient's platelet count was below the typical diagnostic threshold for ET (600 x 10^9/L).

    Findings:

    • Both thrombocytosis and platelet dysfunction contribute to thrombo-hemorrhagic phenomena in ET.
    • Qualitative platelet abnormalities appear to be a primary cause of thromboembolic events in ET, even with lower platelet counts.

    Related Experiment Videos

    Implications:

    • This suggests a need to evaluate platelet function in ET diagnosis and risk assessment.
    • Understanding platelet dysfunction is crucial for managing neurologic complications in Essential thrombocythemia.
    • Clinical guidelines for ET may need revision to incorporate platelet function testing.